1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies




As the oncology drug market continues to face significant road bumps in terms of development costs and pricing requirements, the role of Medical Affairs teams working with oncologists becomes ever more critical.

Fine tuning their performance through smarter delivery and high quality interaction is an increasingly important aspect of establishing and maintaining front line, product level access and education.

In Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies, FirstWord provides robust insight on the performance and physician satisfaction across 12 Medical Affairs teams across 4 key indications; Breast Cancer, Melanoma, Non-Small Cell Lung Cancer (NSCLC) and Renal Cell Carcinoma.

Using its proprietary analytics, EdgeMap and Need-Gap analysis, FirstWord offers an important new advanced analysis of survey results that is both timely and critical to the current oncology drugs market.

EdgeMap

What is EdgeMap Analysis?
This report includes slides that provide advance analysis of the survey results using EdgeMap analysis, a proprietary analytics tool. EdgeMap provides an integrated, comparative analysis of the competitive set of products being evaluated in the study. It offers an overview of the market and provides a clear portrait of each product’s position within its competitive environment.









Key Benefits

In this report, gain insight from key pharma stakeholders with a vested interest in physician perspectives on oncology brand performance.

Gain insight into how oncologists and haematologist-oncologists rate Medical Affairs teams in the areas of Breast Cancer, Melanoma, NSCLC, and Renal Cell Carcinoma
Understand the key issues for which physicians require Medical Affairs team support
Learn which attributes physicians most value in relation to Medical Affairs team services
Identify which marketed and pipeline products were rated most highly across numerous measures
Determine which media and frequency of interaction is perceived the most positively
Benefit from FirstWord’s proprietary analytics tool, EdgeMap and Need-Gap. EdgeMap offers an integrated, comparative analysis of the evaluated products. Need-Gap provides guidance on opportunities for brand positioning and communication.

Key Fact: Interviewing Methodology
Data was collected via a 15-minute Internet-based questionnaire.

Top Report Features

Filled with charts and up-to-the-minute survey analysis, this report offers:

Precise and timely EdgeMap and Need-Gap analytics into the perceptions around Medical Affairs team performances and areas of improvement
Overview of key rankings for eight marketed and four pipeline products
Examination of physicians’ current usage of Medical Affairs teams services
Key findings regarding the most and least important attributes of Medical Affairs teams to physicians


Sample Distribution

Key Fact: Sample Distribution
A total of 100 medical oncologists and hematologist-oncologists across US participated in this study.
70 Medical Oncologists, 30 Hematologist-oncologists



Get Answers to these Questions
How do oncologists perceive the role of Medical Affairs teams in the areas of Breast Cancer, Melanoma, NSCLC, and Renal Cell Carcinoma?
How do physicians use Medical Affairs teams’ services?
What is the optimal frequency of interactions between Medical Affairs teams and physicians?
What is each product’s position within its competitive environment?
Which attributes of Medical Affairs teams are most likely to drive competitive advantage?
Which drugs offered the best service and claimed the highest ratings for Medical Affairs support?
What are the opportunities for corporate and brand positioning and communication?



NeedGap

What is Need-Gap Analysis?

This report includes slides that provide advance analysis of the survey results using Need-Gap analysis, a proprietary analytics tool. Need-Gap Analysis is useful for establishing areas of unmet need and hence provides valuable guidance on opportunities for corporate and brand positioning and communication.


Key Takeaways

Medical Affairs teams, Marketing Directors and Competitive Intelligence units can use this report to:

More precisely analyse physicians’ needs and areas of concern
Improve team responsiveness and traction with oncologists
Better deliver key messaging and identify areas of weakness
Provide accurate, scientifically up-to-date product information in the areas of the most need
Understand how competitors are performing and what improvements need to be made
Tailor interaction frequency, media and approach


Screening Criteria

Key Fact: Screening Criteria

Respondents were screened to ensure these requirements were met:

See at least 5 patients for NSCLC, Melanoma, RCC and breast cancer (for each condition), and they see at least 100 patients in a typical month
Have been in active practice between 5-35 years
Devote at least 50% of time to direct patient care
Interaction with the medical affairs professional in the past 6 months for at least one of the listed products




Table Of Contents

Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies
1.Current Status of Interactions with Different Medical Affairs Teams
1.1.Interactions in the past 6 months with medical affairs teams for each product
1.2.Details of interactions on different aspects
1.3.Current frequency of interactions with medical affair teams for each product

2.Competitive Evaluation of Medical Affairs Teams Performance on Various Attributes
2.1.Evaluation of overall quality of interactions with medical affairs teams for each product
2.2.Attribute importance of medical affairs teams roles to physicians' practice
2.3.EdgeMap analysis by therapy area - competitive evaluation on medical affairs teams performance on attributes
2.4.Competitive evaluation of physicians satisfaction of interaction with medical affairs
2.5.Need-Gap analysis by product

3.Preferred Interaction Media, Frequency, and Suggestions for Improvement
3.1.Preferred interaction media and frequency
3.2.Suggestions for improvement

4.Appendix
4.1.Physician profile
4.2.Detailed satisfaction scores

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Lung Cancer: Analytical Tool

August 2016 $ 8096

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

Download Unlimited Documents from Trusted Public Sources

Cancer Statistics in the US and South Korea

  • November 2016
    2 pages
  • Cancer  

  • United States  

    South Korea  

View report >

Therapy Market in the UK

  • November 2016
    11 pages
  • Therapy  

  • United Kingdom  

View report >

Cancer and Breast Cancer Statistics in the US

  • November 2016
    9 pages
  • Cancer  

    Breast Cancer  

    Cytokine  

  • United States  

View report >

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.